NDC 50090-6180 – Menquadfi
Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen 10 ug/.5mL; Neisseria Meningitidis Group C Capsular Polysaccharide… · Injection, Solution · Intramuscular
Product NDC50090-6180
Product details
- Brand name
- Menquadfi
- Generic name
- NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
- Labeler
- A-S Medication Solutions
- Dosage form
- Injection, Solution
- Route
- Intramuscular
- Marketing category
- BLA · BLA125701
- Marketed since
- April 23, 2020
- Listing expires
- December 31, 2026
Active ingredients
- Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen 10 ug/.5mL
- Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen 10 ug/.5mL
- Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen 10 ug/.5mL
- Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen 10 ug/.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50090-6180-0 | 5 VIAL, SINGLE-DOSE in 1 CARTON (50090-6180-0) / .5 mL in 1 VIAL, SINGLE-DOSE (50090-6180-1) | Apr 23, 2020 |
Other Menquadfi products
- 49281-590 Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid… · Injection, Solution · Sanofi Vaccines US Inc.